Description
2-deoxy-D-glucoseinhibitsglucosemetabolismandisusedasabioMarkerofglucosemetabolism,hypoxia,andangiogenesisinavarietyofmodelsandcelltypes,includingneurotoxicity,cancer,andautoimmunedisease;the2-OHgroupofglucoseisreplacedbyahydrogenandthereforethiscompoundcannotbemetabolizedproperly.2-deoxy-D-glucoseinhibitsN-linkedglycosylationandglycolysis,inhibitingsurfaceexpressionofMICA/BandotherNKG2Dligandsoncells.Thiscompoundalsoexhibitsanticancerandpro-oxidativeactivities,increasingoxidativestressandmimickingglucosedeprivation,resultingincelldeathofcancercells.
References
KairaK,MurakamiH,EndoM,etal.BIOLOGicalcorrelationof(18)F-FDGuptakeonPETinpulmonaryneuroendocrinetumors.AnticancerRes.2013Oct;33(10):4219-28.PMID:24122985.
AndresenL,SkovbakkeSL,PerssonG,etal.2-deoxyD-glucosepreventscellsurfaceexpressionofNKG2DligandsthroughinhibitionofN-linkedglycosylation.JImmunol.2012Feb15;188(4):1847-55.PMID:22227571.
ShuttDC,O"DorisioMS,Aykin-BurnsN,etal.2-deoxy-D-glucoseinducesoxidativestressandcellkillinginhumanneuroblastomacells.CancerBiolTher.2010Jun1;9(11):853-61.PMID:20364116.
NowakM,CarrasquilloJA,YarboroCH,etal.Apilotstudyoftheuseof2-[18F]-fluoro-2-deoxy-D-glucose-positronemissiontomographytoassessthedistributionofactivatedlymphocytesinpatientswithsystemiclupuserythematosus.ArthritisRheum.2004Apr;50(4):1233-8.PMID:15077306.
BöhmerR,RommelK.Thebehaviourofdifferentmarkersofthemucosalextracellularspaceinratsmallintestine.ActaHepatogastroenterol(Stuttg).1975Dec;22(6):398-403.PMID:1211066.